Exploiting knowledge on pharmacodynamics-pharmacokinetics for accelerated anti-leishmanial drug discovery/development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Exploiting knowledge on pharmacodynamics-pharmacokinetics for accelerated anti-leishmanial drug discovery/development

Published:2019-06-17 Issue:7 Volume:15 Page:595-612
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Sundar Shyam¹,Agrawal Neha²,Singh Bhawana¹³

Affiliation:

1. Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India

2. Hepatology, Temple University, Philadelphia, PA, USA

3. Department of Pathology, Wexner Medical Center, The Ohio State University, Columbus, OH, USA

Funder

the National Institute of Allergy and Infectious Diseases (NIH)

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2019.1629417

Reference212 articles.

1. Leishmaniasis Worldwide and Global Estimates of Its Incidence

2. Identifying vaccine targets for anti-leishmanial vaccine development

3. Emerging therapeutic targets for treatment of leishmaniasis

4. Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases

5. Human Leishmaniasis: Clinical, Diagnostic, and Chemotherapeutic Developments in the Last 10 Years

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the peculiarities and development of novel inhibitors of leishmanial arginyl‐tRNA synthetase;The FEBS Journal;2024-03-25

2. Molecular-level strategic goals and repressors in Leishmaniasis – Integrated data to accelerate target-based heterocyclic scaffolds;European Journal of Medicinal Chemistry;2023-09

3. Advances in Understanding Leishmania Pathobiology: What Does RNA-Seq Tell Us?;Frontiers in Cell and Developmental Biology;2021-09-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3